SecBot SecBot

Joe Fiandra Access to Home Infusion Act of 2025

H.R. 4993 Rep. Brian Fitzpatrick (R-PA-1) In committee
Bill text PDF
  1. Introduced Aug 19
  2. Committee Aug 19
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Aug 19, 2025Next: House vote
321d ago Dec 10, 2025: Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 5 filings
Subscribe to see spend
Member trades
1trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe

Summary

Joe Fiandra Access to Home Infusion Act of 2025

Full summary2 paragraphs

This bill provides for Medicare coverage of certain home infusion drugs that are administered by health care professionals at a beneficiary’s home.

Specifically, the bill provides for coverage of external infusion pumps and associated home infusion drugs for which (1) the prescription requires that the drug be administered by or under the supervision of a health care professional, (2) a qualified home infusion therapy supplier administers or supervises the administration of the drug at the beneficiary's home, and (3) the prescription requires that the drug be infused at least 12 times per year in a manner that requires the use of an external infusion pump.

Library of Congress summary, Aug 19, 2025

Summary versions
  • Introduced in HouseAug 19, 2025

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.